Baskent University Istanbul Hospital provides specialised Papillary Thyroid Cancer Treatment with a focus on accurate diagnosis, individualised treatment, and long-term cancer management. Established in 1993, the JCI, ISO hospital is located in Istanbul, Turkey and operates 144 beds with modern oncology infrastructure.

Papillary Thyroid Cancer Treatment aims to effectively control the cancer while preserving thyroid-related health and minimising unnecessary treatment. Depending on the patient's risk profile, management may involve thyroid surgery, radioactive iodine therapy, thyroid hormone replacement, or active surveillance. In advanced or recurrent cases, additional systemic treatments may be considered. Doctors typically use imaging, biopsy, blood tests, and pathology findings to guide treatment decisions, and then conduct regular monitoring for recurrence and thyroid function.